Chambers David W
Arthur A. Dugoni School of Dentistry, University of the Pacific, 2155 Webster Street, San Francisco, CA 94115, USA.
Med Health Care Philos. 2011 May;14(2):133-42. doi: 10.1007/s11019-010-9255-2.
Despite its several variations, the central position of equipoise is that subjects in clinical experiments should not be randomized to conditions when others believe that better alternatives exist. This position has been challenged over issues of which group in the medical or research community is authorized to make that determination, and it has been argued that informed consent provides sufficient ethical protection for participants independent of equipoise. In this paper I frame ethical participation in clinical research as a two-party decision process involving offering and accepting participation under informed consent. Nine conditions are identified in which it is possible that potential participants and researchers or care professionals can rationally choose divergent actions based on identical understandings of the situation. Under such circumstances, researchers or care professionals cannot ethically substitute their understanding of equipoise in the situation for the patients' choices, or vice versa.
尽管存在多种变体,但均衡的核心观点是,当其他人认为存在更好的选择时,临床实验中的受试者不应被随机分配到不同条件下。这一观点在医学或研究界中由哪一方有权做出该决定的问题上受到了挑战,并且有人认为,知情同意为参与者提供了独立于均衡的充分伦理保护。在本文中,我将临床研究中的伦理参与构建为一个双方决策过程,该过程涉及在知情同意的情况下提供和接受参与。确定了九种情况,在这些情况下,潜在参与者与研究人员或护理专业人员有可能基于对情况的相同理解而合理地选择不同的行动。在这种情况下,研究人员或护理专业人员在伦理上不能用他们对情况的均衡理解来替代患者的选择,反之亦然。